Elevated levels of GAS5 decreased the expression of miR-222 through directly targeting in glioma cells; meanwhile, tumor suppressor Bcl-2-modifying factor (bmf), as the downstream target of miR-222, was up-regulated, and thus inhibited glioma cell proliferation [7]. Here, GAS5 is linked to glioma.